Skip to main content
. 2021 Sep 24;3(12 Suppl):S209–S217. doi: 10.1016/j.cjco.2021.09.015

Table 2.

Study patient characteristics by sex, race, and age from included implantable cardioverter–defibrillator randomized controlled trials (ICD RCTs)

Characteristic ICD arm (n = 3260) Comparator arm (n = 3018) Comparator arm 2 (n = 847)
Age, y
Mean 62.9 ± 4.0 63.1 ± 4.3 NR
Median 62.1 61.7 59.1
Sex, % of n
 Male 77.5 77.5 77.0
 Female 22.5 22.5 23.0
Race, % of n
 White 75.8 77.1 NR
 Black 17.3 16.9 NR
 Hispanic 5.7 5.7 NR
 East Asian 0 0.4 NR
 Southeast Asian NR NR NR
 Other 12.0 12.0 24.0

NR, not reported.

Comparator arm included either standard medical therapy, usual clinical care, treatment with amiodarone, conventional medical therapy, or ICD-CRT. Comparator arm 2 was composed of a placebo arm from Russo et al.15

Other” includes all non-White races as reported in one study, but these were unspecified by Russo et al.15